Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
about
Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expressionMitochondrial function and regulation of macrophage sterol metabolism and inflammatory responsesCell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexesT cells in atherosclerosis11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ miceContribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and AutoimmunityHMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrinBeginnings of a good apoptotic meal: the find-me and eat-me signaling pathwaysRab17 mediates differential antigen sorting following efferocytosis and phagocytosis.The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.The role of necroptosis in atherosclerotic disease.Macrophage polarization in inflammatory diseases.Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcificationInterleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiencyControl of macrophage activation and function by PPARs.Galectin-3 is a new MerTK-specific eat-me signal.Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis.Hemodialysis removes uremic toxins that alter the biological actions of endothelial cellsmiR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.Signaling through LRP1: Protection from atherosclerosis and beyondThe Role of Efferocytosis in Atherosclerosis.Identification of aortic arch-specific quantitative trait loci for atherosclerosis by an intercross of DBA/2J and 129S6 apolipoprotein E-deficient miceInterleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory responseRegulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Conceptual approaches to lung injury and repair.ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms.Ethanol extract of propolis protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting CD36 expression and endoplasmic reticulum stress-C/EBP homologous protein pathwayBeyond genome-wide association studies: the usefulness of mouse genetics in understanding the complex etiology of atherosclerosis.Oxysterols as non-genomic regulators of cholesterol homeostasis.Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stressReactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis.Mer receptor tyrosine kinase mediates both tethering and phagocytosis of apoptotic cells.Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice.Fibrocytes: emerging effector cells in chronic inflammationMacrophages: Their Emerging Roles in Bone.CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.CYP450-derived oxylipins mediate inflammatory resolution.Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
P2860
Q24314933-58098BA8-4BD2-4AB4-B3BC-5DA8A9DAA558Q26825337-46838B3E-0CE2-463D-A8EA-72B351FB67F6Q27008742-5E56EA48-6C36-496F-A8AC-0BBC8211C62CQ27025697-99284F21-6092-452A-92F0-50927F44E278Q27322801-A37DEF3A-07F6-4FAC-86C7-DEF8A57123E2Q28397407-C1D986D7-1BB4-4E78-8E30-135C6645AD50Q28506871-4DBD3BAA-AE77-473D-A991-1A43E19BB2EDQ30424410-CF6AE15A-1770-40D5-A9D9-A8032873E15AQ30836198-EDB57022-848C-4CAD-A1E9-EC401DCA4022Q33586616-B4E8C0B2-2BA6-43B6-8696-7F26CE4E044EQ33643471-2D42AC57-F690-473C-9C5A-11AE469F7918Q33716370-3CCEE26A-E4CE-47CC-82B7-1ABD63D06346Q33858743-408A3B46-5790-46A7-89DE-0BD7DC4518FDQ33881232-FD6A5717-DAFB-469C-8727-8BDA95664DB6Q33962601-067ABA15-A639-4AAC-83A1-349F9DE23919Q33972695-F3671503-70EF-432C-9692-819AD9228763Q34107357-07A26F30-FE5A-4854-B7DD-9A5A624E261BQ34181580-55AF805D-5AB6-46A0-B828-923A3054C5F8Q34324735-DC81C10F-807D-4CEE-B26B-0D9A18E81449Q34348612-F25503BD-30EF-48FE-97E1-764C64397CD6Q34680660-5AC38E2B-6688-403D-9D27-172DA48AA642Q35092338-9D0527B2-E5D2-47C1-8F0A-B331C3D68F2CQ35183021-0325489C-4ED6-4C5B-9B43-1FC14CC49F96Q35551835-569BE26C-7371-42EB-8783-3E78F169F5F8Q35604431-123EF9FD-5EA5-4FF4-ABFC-A53B8955913FQ35629054-2F345F3B-E355-42A3-813C-C4857AB3C035Q35673049-D00CEEC2-80F4-4453-B307-AED32EBC7D01Q35689909-E834530A-6EB9-4201-9589-CF69F461271AQ35739449-810096ED-014F-4C58-8D63-445F56F770A6Q35803140-7E006645-4FA1-40CD-854C-7C71308EE241Q35886261-5D183FF5-883B-4084-B441-3504A6497910Q36201919-9A4C54F2-083A-406B-A6C4-B6E1EAB26EFEQ36326562-3C671CB8-6A1E-4997-931B-2D0932CBE620Q36347294-E42ADA6D-0679-4F05-9CF8-26ED19FD241FQ36438873-42879301-2F7E-42C2-A39E-123112181131Q36690680-5A13EB53-7BBC-4832-80FD-E8AC31AC0911Q36926240-BB71EF2A-BCDE-4FD2-BA46-8BA4D397ACFDQ37165792-F0265B4E-6E47-4871-968E-8013458EF986Q37183722-6FA1F140-38C1-4373-8398-6306FEB0CC5AQ37342782-9B198D88-8F44-4139-AA28-85812FAF548A
P2860
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
@en
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
@nl
type
label
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
@en
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
@nl
prefLabel
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
@en
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
@nl
P2860
P356
P1476
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
@en
P2093
Edward Thorp
P2860
P304
P356
10.1189/JLB.0209115
P577
2009-05-04T00:00:00Z